Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in June
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that Dave Stack, president, chief executive officer and chairman of Pacira Pharmaceuticals, is scheduled to present an overview of the company at the following investor conferences in June:
- Jefferies 2015 Global Healthcare Conference at 11:30 a.m. ET in New York on Monday, June 1, 2015.
- Goldman Sachs 36th Annual Global Healthcare Conference at 10:40 a.m. PT in Rancho Palos Verdes, California on Tuesday, June 9, 2015.
Live audio webcasts of the Pacira presentations can be accessed by visiting the “Investors & Media” section of the company’s website at investor.pacira.com. Replays of the webcasts will be archived on the Pacira website for two weeks following the respective presentation dates.
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company’s flagship product, EXPAREL(R) (bupivacaine liposome injectable suspension), indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia, was commercially launched in the United States in April 2012. EXPAREL and two other products have successfully utilized DepoFoam(R), a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. Additional information about Pacira is available at www.pacira.com.
Sorry. No data so far.